These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 9368834

  • 1. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A.
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [Abstract] [Full Text] [Related]

  • 2. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P, Fulghesu AM, De Marinis L, Valle D, Mancini A, Pavone V, Caruso A, Lanzone A.
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [Abstract] [Full Text] [Related]

  • 3. Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects.
    Villa P, Valle D, De Marinis L, Mancini A, Bianchi A, Fulghesu AM, Caruso A, Mancuso S, Lanzone A.
    Eur J Endocrinol; 1997 Dec; 137(6):631-4. PubMed ID: 9437228
    [Abstract] [Full Text] [Related]

  • 4. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Ferdeghini M, Genazzani AR.
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [Abstract] [Full Text] [Related]

  • 5. The IGF-I response to very low rhGH doses is preserved in human ageing.
    Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E.
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):757-63. PubMed ID: 10209563
    [Abstract] [Full Text] [Related]

  • 6. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG, Ropelato MG, Domené HM, Pennisi P, Heinrich JJ, Jasper HG.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [Abstract] [Full Text] [Related]

  • 7. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P, Valle D, Mancini A, De Marinis L, Pavone V, Fulghesu AM, Mancuso S, Lanzone A.
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [Abstract] [Full Text] [Related]

  • 8. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP.
    Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
    [Abstract] [Full Text] [Related]

  • 9. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 12. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A, Bini V, Cabiati G, Papi F, Arzano S, Celi F, Sanasi M.
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [Abstract] [Full Text] [Related]

  • 14. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 15. The effect of growth hormone on bioactive IGF in overweight/obese women.
    Dichtel LE, Bjerre M, Schorr M, Bredella MA, Gerweck AV, Russell BM, Frystyk J, Miller KK.
    Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
    [Abstract] [Full Text] [Related]

  • 16. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG.
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [Abstract] [Full Text] [Related]

  • 18. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population.
    Granada ML, Murillo J, Lucas A, Salinas I, Llopis MA, Castells I, Foz M, Sanmartí A.
    Eur J Endocrinol; 2000 Mar; 142(3):243-53. PubMed ID: 10700718
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.